Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olive Oil vs. Bran Oil in Type 2 Diabetes
NCT03544411Phase 1Completed
- Sponsor
- Universitas Indonesia
- Start
- Jul 2018
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Change of malondialdehyde at Day 70. Started Jul 2018; status: completed.
Beyond the preview
Go deeper on NCT03544411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03544411.